Cargando…
Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma
BACKGROUND: There are currently no treatments targeting the immune microenvironment (TME) as an extension of immunotherapy. Our research aims to provide guidance for the development of immune-related mRNA vaccines and the identification of immune subtypes for vaccine treatment in lung adenocarcinoma...
Autores principales: | Zhao, Deze, Liu, Xianyu, Shan, Yunhan, Li, JiaJia, Cui, Weifang, Wang, Jun, Jiang, Junjie, Xie, Qun, Zhang, Chunfang, Duan, Chaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483806/ https://www.ncbi.nlm.nih.gov/pubmed/36187916 http://dx.doi.org/10.1016/j.csbj.2022.08.066 |
Ejemplares similares
-
Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients
por: Liu, Xianyu, et al.
Publicado: (2022) -
tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application
por: Li, Xizhe, et al.
Publicado: (2021) -
tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets
por: Cui, Weifang, et al.
Publicado: (2023) -
Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2022) -
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)